Test Price
3,500 AEDโ Home Collection Available
๐ Results in 10 working days
Cancer Targeted Gene Panel (Lung) in UAE | 3500 AED | DHA Licensed
Executive Summary & Core Metrics
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS & FISH Processing
- โ Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval โ Archival FFPE blocks accepted
- โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a multidisciplinary team
- โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The Cancer Targeted Gene Panel (Lung) is a comprehensive NGS and FISH analysis that detects actionable mutations, fusions, and copy number changes in lung cancer tissue, enabling precision oncology decisions. The test is performed on a formalin-fixed paraffin-embedded (FFPE) tumor block or biopsy slides. Key clinical specialists involved: Medical Oncologist (treatment planning), Pulmonologist (diagnostic biopsy & interpretation), Pathologist (tissue adequacy & genetic interpretation).
| Feature | Our Test (NGS & FISH Panel) | Closest Alternative (Single Gene PCR) |
|---|---|---|
| Precision | 99.9% Sensitivity, multiple biomarkers | Single mutation, up to 95% sensitivity |
| Method | Next Generation Sequencing + FISH | PCR / Sanger Sequencing |
| Speed | Report in 10 working days | 5โ7 working days |
| Coverage | ALK, ROS1, EGFR, KRAS, BRAF & more | Single gene of interest |
Physician Insight & Safety Protocols
A Note from Mr. Prabhakar Reddy Kalathoor
As a Specialist Diagnostic Radiology with DHA Registration ID 61713011, I emphasize that this panel is a powerful tool to guide precision therapy. It must be interpreted in the full clinical context by your multidisciplinary team, including a medical oncologist, pulmonologist, and pathologist. This test does not replace the need for expert clinical evaluation and shared decision-making.
Advisory & Safety Precautions
Exclusion Criteria & Emergency Red Flags
- Inadequate tumor tissue (<20% tumour content) or insufficient formalin-fixed paraffin-embedded (FFPE) block.
- Informed consent not obtainable in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Patient is medically unstable or cannot undergo biopsy.
- ER Red Flags: If after biopsy you experience acute chest pain, hemoptysis, severe shortness of breath, or fever, seek emergency care immediately.
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
1. What is the Cancer Targeted Gene Panel (Lung) test?
This test detects actionable mutations in lung cancer genes via NGS and FISH analysis performed on a biopsy or surgical FFPE block. It identifies oncogenic drivers like EGFR, ALK, ROS1 to guide targeted and immunotherapy decisions.
2. Why do I need this test?
Knowing the molecular profile of your lung cancer helps your oncologist choose the most effective and least toxic therapy, avoiding ineffective treatments. It identifies actionable mutations for targeted therapies.
3. How should I prepare and what are the risks?
Your doctor will submit a tumor tissue block; no fasting is required. There are no direct risks from the laboratory analysis because it is performed on already collected tissue. However, the original biopsy may carry procedural risks discussed with your pulmonologist. Ensure the NGS Requisition Form (Form 40) is completed.
4. How long does it take to get results?
The clinical report is issued within 10 working days from receipt of the specimen in the laboratory.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. The processing laboratory holds ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Cancer Targeted Gene Panel (Lung) |
| Price (AED) | 3,500 AED |
| Turnaround Time | 10 working days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides โ Archival Specimen |
| Methodology Used | Next Generation Sequencing (NGS) & Fluorescence In Situ Hybridization (FISH) |
| ICD-10-CM Code | C34.9 (Malignant neoplasm of bronchus or lung, unspecified) |
| LOINC Code | 75504-0 (Oncology panel - Lung cancer) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No fasting required", "Ensure the NGS Requisition Form (Form 40) is completed"]
Medically Reviewed by Dr. Dr. Prabhakar Reddy Kalathoor
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians